Oral dabigatran etexilate versus enoxaparin for venous thromboembolism prevention after total hip arthroplasty: pooled analysis of two phase 3 randomized trials

Two phase 3 trials compared 28-35 days of treatment with oral dabigatran 220 mg or 150 mg (RE-NOVATE) or 220 mg (RE-NOVATE II) once daily with subcutaneous enoxaparin 40 mg once daily for prevention of venous thromboembolism (VTE) after elective total hip arthroplasty.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Eriksson, Bengt (VerfasserIn) , Dahl, Ola E. (VerfasserIn) , Rosencher, Nadia (VerfasserIn) , Clemens, Andreas (VerfasserIn) , Hantel, Stefan (VerfasserIn) , Feuring, Martin (VerfasserIn) , Kreuzer, Jörg (VerfasserIn) , Huo, Michael (VerfasserIn) , Friedman, Richard J. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 17 November 2015
In: Thrombosis journal
Year: 2015, Jahrgang: 13
ISSN:1477-9560
DOI:10.1186/s12959-015-0067-8
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s12959-015-0067-8
Volltext
Verfasserangaben:Bengt I. Eriksson, Ola E. Dahl, Nadia Rosencher, Andreas Clemens, Stefan Hantel, Martin Feuring, Jörg Kreuzer, Michael Huo and Richard J. Friedman

MARC

LEADER 00000caa a2200000 c 4500
001 1725019817
003 DE-627
005 20240406193241.0
007 cr uuu---uuuuu
008 200716s2015 xx |||||o 00| ||eng c
024 7 |a 10.1186/s12959-015-0067-8  |2 doi 
035 |a (DE-627)1725019817 
035 |a (DE-599)KXP1725019817 
035 |a (OCoLC)1341346874 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Eriksson, Bengt  |e VerfasserIn  |0 (DE-588)1205920773  |0 (DE-627)1691764477  |4 aut 
245 1 0 |a Oral dabigatran etexilate versus enoxaparin for venous thromboembolism prevention after total hip arthroplasty  |b pooled analysis of two phase 3 randomized trials  |c Bengt I. Eriksson, Ola E. Dahl, Nadia Rosencher, Andreas Clemens, Stefan Hantel, Martin Feuring, Jörg Kreuzer, Michael Huo and Richard J. Friedman 
264 1 |c 17 November 2015 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 16.07.2020 
520 |a Two phase 3 trials compared 28-35 days of treatment with oral dabigatran 220 mg or 150 mg (RE-NOVATE) or 220 mg (RE-NOVATE II) once daily with subcutaneous enoxaparin 40 mg once daily for prevention of venous thromboembolism (VTE) after elective total hip arthroplasty. 
700 1 |a Dahl, Ola E.  |e VerfasserIn  |4 aut 
700 1 |a Rosencher, Nadia  |e VerfasserIn  |4 aut 
700 1 |a Clemens, Andreas  |e VerfasserIn  |4 aut 
700 1 |a Hantel, Stefan  |e VerfasserIn  |4 aut 
700 1 |a Feuring, Martin  |d 1963-2018  |e VerfasserIn  |0 (DE-588)1075744083  |0 (DE-627)833665383  |0 (DE-576)176498125  |4 aut 
700 1 |a Kreuzer, Jörg  |d 1960-  |e VerfasserIn  |0 (DE-588)1106567757  |0 (DE-627)863176259  |0 (DE-576)17820997X  |4 aut 
700 1 |a Huo, Michael  |e VerfasserIn  |4 aut 
700 1 |a Friedman, Richard J.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Thrombosis journal  |d London : Biomed Central, 2003  |g 13(2015) Artikel-Nummer 36, 9 Seiten  |h Online-Ressource  |w (DE-627)369082982  |w (DE-600)2118392-2  |w (DE-576)107015706  |x 1477-9560  |7 nnas  |a Oral dabigatran etexilate versus enoxaparin for venous thromboembolism prevention after total hip arthroplasty pooled analysis of two phase 3 randomized trials 
773 1 8 |g volume:13  |g year:2015  |g extent:9  |a Oral dabigatran etexilate versus enoxaparin for venous thromboembolism prevention after total hip arthroplasty pooled analysis of two phase 3 randomized trials 
856 4 0 |u https://doi.org/10.1186/s12959-015-0067-8  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200716 
993 |a Article 
994 |a 2015 
998 |g 1106567757  |a Kreuzer, Jörg  |m 1106567757:Kreuzer, Jörg  |d 50000  |e 50000PK1106567757  |k 0/50000/  |p 7 
998 |g 1075744083  |a Feuring, Martin  |m 1075744083:Feuring, Martin  |d 60000  |e 60000PF1075744083  |k 0/60000/  |p 6 
999 |a KXP-PPN1725019817  |e 3725356874 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedDisp":"17 November 2015","dateIssuedKey":"2015"}],"id":{"eki":["1725019817"],"doi":["10.1186/s12959-015-0067-8"]},"name":{"displayForm":["Bengt I. Eriksson, Ola E. Dahl, Nadia Rosencher, Andreas Clemens, Stefan Hantel, Martin Feuring, Jörg Kreuzer, Michael Huo and Richard J. Friedman"]},"physDesc":[{"extent":"9 S."}],"relHost":[{"origin":[{"publisherPlace":"London","dateIssuedDisp":"2003-","publisher":"Biomed Central","dateIssuedKey":"2003"}],"title":[{"title_sort":"Thrombosis journal","title":"Thrombosis journal"}],"id":{"issn":["1477-9560"],"eki":["369082982"],"zdb":["2118392-2"]},"pubHistory":["1.2003 -"],"part":{"year":"2015","extent":"9","text":"13(2015) Artikel-Nummer 36, 9 Seiten","volume":"13"},"physDesc":[{"extent":"Online-Ressource"}],"disp":"Oral dabigatran etexilate versus enoxaparin for venous thromboembolism prevention after total hip arthroplasty pooled analysis of two phase 3 randomized trialsThrombosis journal","type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"recId":"369082982"}],"title":[{"title":"Oral dabigatran etexilate versus enoxaparin for venous thromboembolism prevention after total hip arthroplasty","subtitle":"pooled analysis of two phase 3 randomized trials","title_sort":"Oral dabigatran etexilate versus enoxaparin for venous thromboembolism prevention after total hip arthroplasty"}],"person":[{"family":"Eriksson","given":"Bengt","roleDisplay":"VerfasserIn","display":"Eriksson, Bengt","role":"aut"},{"given":"Ola E.","family":"Dahl","role":"aut","display":"Dahl, Ola E.","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Rosencher, Nadia","given":"Nadia","family":"Rosencher"},{"role":"aut","display":"Clemens, Andreas","roleDisplay":"VerfasserIn","given":"Andreas","family":"Clemens"},{"given":"Stefan","family":"Hantel","role":"aut","roleDisplay":"VerfasserIn","display":"Hantel, Stefan"},{"display":"Feuring, Martin","roleDisplay":"VerfasserIn","role":"aut","family":"Feuring","given":"Martin"},{"role":"aut","display":"Kreuzer, Jörg","roleDisplay":"VerfasserIn","given":"Jörg","family":"Kreuzer"},{"family":"Huo","given":"Michael","roleDisplay":"VerfasserIn","display":"Huo, Michael","role":"aut"},{"role":"aut","display":"Friedman, Richard J.","roleDisplay":"VerfasserIn","given":"Richard J.","family":"Friedman"}],"note":["Gesehen am 16.07.2020"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"recId":"1725019817"} 
SRT |a ERIKSSONBEORALDABIGA1720